• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区中痴呆症患者睡眠障碍的患病率:系统评价和荟萃分析。

Prevalence of sleep disturbances in people with dementia living in the community: A systematic review and meta-analysis.

机构信息

Division of Psychiatry, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London W1T 7NF, UK.

Division of Psychology and Language Sciences, University College London, 26 Bedford Way, London WC1H 0AP, UK.

出版信息

Ageing Res Rev. 2023 Jan;83:101782. doi: 10.1016/j.arr.2022.101782. Epub 2022 Nov 7.

DOI:10.1016/j.arr.2022.101782
PMID:36356799
Abstract

This study aimed to systematically review and meta-analyse the prevalence of sleep disturbances in people with dementia and examine demographic predictors and whether overall prevalence has changed over time. We searched Embase, MEDLINE and PsycINFO for studies reporting the prevalence of sleep disturbances in people with dementia living at home. We meta-analysed the data and calculated the pooled prevalence of sleep disturbances in people with dementia overall and in dementia subtypes. We used meta-regressions to investigate the effects of study characteristics, publication dates and participant demographics. Eleven studies fulfilled the inclusion criteria. The pooled prevalence of any symptoms of sleep disturbance was 26 % (95 % confidence intervals, CI: 23-30 %; n = 2719) and of clinically significant sleep disturbance 19 % (13-25 %; n = 2753). The pooled prevalence of sleep disturbance symptoms was significantly lower among people with Alzheimer's disease (24 %; 16-33 %, n = 310) than Lewy body dementia (49 %; 37-61 %, n = 65). Meta-regression analysis did not find that publication year, participant's age, sex and study quality predicted prevalence. Sleep disturbances are common among people with dementia living in the community, especially in Lewy body dementia. There was no change in prevalence according to publication dates, suggesting treatment has not improved over time.

摘要

本研究旨在系统地综述和荟萃分析痴呆患者睡眠障碍的患病率,并探讨人口统计学预测因素,以及总体患病率是否随时间发生变化。我们在 Embase、MEDLINE 和 PsycINFO 中搜索了报告居家痴呆患者睡眠障碍患病率的研究。我们对数据进行荟萃分析,并计算了痴呆患者整体和各亚型睡眠障碍的汇总患病率。我们使用荟萃回归分析来探讨研究特征、发表日期和参与者人口统计学的影响。有 11 项研究符合纳入标准。任何睡眠障碍症状的总患病率为 26%(95%置信区间,CI:23-30%;n=2719),临床显著睡眠障碍的患病率为 19%(13-25%;n=2753)。在阿尔茨海默病患者(24%;16-33%,n=310)中,睡眠障碍症状的总患病率明显低于路易体痴呆(49%;37-61%,n=65)。荟萃回归分析未发现发表年份、参与者年龄、性别和研究质量可以预测患病率。睡眠障碍在社区中生活的痴呆患者中很常见,尤其是在路易体痴呆患者中。根据发表日期,患病率没有变化,这表明治疗并没有随着时间的推移而改善。

相似文献

1
Prevalence of sleep disturbances in people with dementia living in the community: A systematic review and meta-analysis.社区中痴呆症患者睡眠障碍的患病率:系统评价和荟萃分析。
Ageing Res Rev. 2023 Jan;83:101782. doi: 10.1016/j.arr.2022.101782. Epub 2022 Nov 7.
2
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
6
Cannabinoids for the treatment of dementia.大麻素治疗痴呆。
Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.
7
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
8
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.抗精神病药治疗阿尔茨海默病和血管性痴呆患者的激越和精神病性症状。
Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.
9
Algorithm-based pain management for people with dementia in nursing homes.基于算法的养老院痴呆患者疼痛管理。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013339. doi: 10.1002/14651858.CD013339.pub2.
10
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.用于纤维肌痛的5-羟色胺和去甲肾上腺素再摄取抑制剂(SNRIs)
Cochrane Database Syst Rev. 2018 Feb 28;2(2):CD010292. doi: 10.1002/14651858.CD010292.pub2.

引用本文的文献

1
Sleep Across the Lifespan: A Neurobehavioral Perspective.全生命周期的睡眠:神经行为学视角
Curr Sleep Med Rep. 2025;11(1):7. doi: 10.1007/s40675-025-00322-2. Epub 2025 Feb 5.
2
Sleep at home for older persons with dementia and their caregivers: a qualitative study of their experiences and challenges.痴呆症老年人及其照顾者在家中的睡眠:对他们经历和挑战的定性研究
Eur J Ageing. 2025 Jun 16;22(1):28. doi: 10.1007/s10433-025-00858-w.
3
Association Between Sleep Quality and Cognitive Complaints Among Young Adults With Migraine.偏头痛青年成人的睡眠质量与认知主诉之间的关联
Cureus. 2025 May 7;17(5):e83649. doi: 10.7759/cureus.83649. eCollection 2025 May.
4
Longitudinal Remote Sleep and Cognitive Research in Older Adults With Mild Cognitive Impairment and Dementia: Prospective Feasibility Cohort Study.轻度认知障碍和痴呆症老年人的纵向远程睡眠与认知研究:前瞻性可行性队列研究
JMIR Aging. 2025 May 28;8:e72824. doi: 10.2196/72824.
5
Long-term health conditions and their impact on people with sleep disturbances and dementia.长期健康状况及其对睡眠障碍和痴呆症患者的影响。
BMC Geriatr. 2025 May 26;25(1):376. doi: 10.1186/s12877-025-06045-x.
6
Hypothalamic volume, sleep, and APOE genotype in cognitively healthy adults.认知健康成年人的下丘脑体积、睡眠与载脂蛋白E基因型
Alzheimers Dement. 2025 May;21(5):e70244. doi: 10.1002/alz.70244.
7
Effectiveness of Non-Pharmacological Interventions for Sleep Disorders in Enhancing Quality of Life, Cognitive Function, and Sleep Quality in Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.非药物干预对轻度认知障碍老年人睡眠障碍改善生活质量、认知功能和睡眠质量的有效性:一项系统评价和荟萃分析
Medicina (Kaunas). 2025 Mar 25;61(4):583. doi: 10.3390/medicina61040583.
8
Process evaluation in a randomised controlled trial of DREAMS-START (dementia related manual for sleep; strategies for relatives) for sleep disturbance in people with dementia and their carers.一项针对痴呆症患者及其照料者睡眠障碍的DREAMS-START(痴呆症相关睡眠手册;亲属策略)随机对照试验的过程评估。
Age Ageing. 2025 Mar 3;54(3). doi: 10.1093/ageing/afaf053.
9
Mindfulness Meditation for Sleep Disturbances Among Individuals with Cognitive Impairment: A Scoping Review.认知障碍个体睡眠障碍的正念冥想:一项范围综述
Healthcare (Basel). 2025 Jan 31;13(3):296. doi: 10.3390/healthcare13030296.
10
A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.一名最初被误诊为阿尔茨海默病的致死性家族性失眠症患者:病例报告
BMC Neurol. 2024 Dec 23;24(1):489. doi: 10.1186/s12883-024-03999-0.